Atrial Natriuretic Factor (1-28) (human) acetate salt

Suppliers

Names

[ CAS No. ]:
89213-87-6

[ Name ]:
Atrial Natriuretic Factor (1-28) (human) acetate salt

[Synonym ]:
Atrial natriuretic peptide (human, 1-28)
α-Humanatrial natriuretic peptide
ANP1-28,HUMAN
HSCH2CH2(NHCO)2(CH2)2CH(CH3)2
α-ANF (1-28), human
Atrial natriuretic peptide-28 (human)
carperitide
Pentanamide,N-[[(2-mercaptoethyl)amino]carbonyl]-4-methyl
(1-28)-Human atrial natriuretic peptide
H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH
L-seryl-L-leucyl-L-arginyl-L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-methionyl-L-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-L-tyrosine cyclic (7->23)-disulfide
Atrial Natriuretic Peptide (1-28), human
Atrial Natriuretic Peptide (ANP) (1-28), human, porcine

Chemical & Physical Properties

[ Density]:
1.6±0.1 g/cm3

[ Molecular Formula ]:
C127H203N45O39S3

[ Molecular Weight ]:
3080.444

[ Exact Mass ]:
3078.444580

[ PSA ]:
1479.28000

[ LogP ]:
-14.30

[ Index of Refraction ]:
1.689

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CJ9920000
CHEMICAL NAME :
Atriopeptin-33(rat), 1-de-L-leucine-2-de-L-alanine-3-deglycine-4-de-L-prol ine-5-de-L-arginine-1 7-L-methionine-
CAS REGISTRY NUMBER :
89213-87-6
LAST UPDATED :
199406
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
Cl27-H203-N45-O39-S3
MOLECULAR WEIGHT :
2512.81

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
110 mg/kg
SEX/DURATION :
female 7-17 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Newborn - behavioral
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 44,495,1992
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
840 mg/kg
SEX/DURATION :
male 9 week(s) pre-mating female 2 week(s) pre-mating - 7 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 44,485,1992

Related Compounds

  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 3-{4-[(Trifluoroacetamido)methyl]piperidin-1-yl}propanoic acid
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • N-[(Z)-benzylideneamino]-5-(2-methoxyphenyl)pyrazolidine-3-carboxamide
  • 5-Fluoro-6-(oxolan-2-yl)-3,4-dihydropyrimidine-4-thione
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • {[1-cyclopropyl-5-(oxan-4-yl)-1H-1,2,3-triazol-4-yl]methyl}(methyl)amine
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide